您当前位置：首页 > 国际期刊-Drug Design Development and Therapy期刊投稿发表详细信息

Drug Design Development and Therapy Q1

期刊收录：
SCIE
Scopus
DOAJ

基本信息

期刊ISSN：
1177-8881
期刊简拼：
DRUG DES DEV THER
年发文章数：
256
E-ISSN：
Gold OA文章占比
97.50%
研究文章占比：
80.08%
是否OA：
Yes
Jcr分区：
Q1
中科院分区：
2区

出版信息

出版商：
Dove Medical Press Ltd.
涉及研究方向：
CHEMISTRY, MEDICINAL-PHARMACOLOGY & PHARMACY
出版国家：
ENGLAND
出版语言：
English
出版周期：
出版年份：
2007

2023-2024最新影响因子:4.7
自引率:2.10%
五年影响因子:4.8
JCI期刊引文指标:1.1
h-index:48
CiteScore:9.00

期刊关键词

1区 SCIE Scopus DOAJ 医学 2区 CHEMISTRY MEDICINAL 药物化学 PHARMACOLOGY & PHARMACY 药学

期刊简介

Drug Design, Development and Therapy is an international, peer-reviewed, open access journal that spans the spectrum of drug design, discovery and development through to clinical applications.

The journal is characterized by the rapid reporting of high-quality original research, reviews, expert opinions, commentary and clinical studies in all therapeutic areas.

Specific topics covered by the journal include:

Drug target identification and validation
Phenotypic screening and target deconvolution
Biochemical analyses of drug targets and their pathways
New methods or relevant applications in molecular/drug design and computer-aided drug discovery*
Design, synthesis, and biological evaluation of novel biologically active compounds (including diagnostics or chemical probes)
Structural or molecular biological studies elucidating molecular recognition processes
Fragment-based drug discovery
Pharmaceutical/red biotechnology
Isolation, structural characterization, (bio)synthesis, bioengineering and pharmacological evaluation of natural products**
Distribution, pharmacokinetics and metabolic transformations of drugs or biologically active compounds in drug development
Drug delivery and formulation (design and characterization of dosage forms, release mechanisms and in vivo testing)
Preclinical development studies
Translational animal models
Mechanisms of action and signalling pathways
Toxicology
Gene therapy, cell therapy and immunotherapy
Personalized medicine and pharmacogenomics
Clinical drug evaluation
Patient safety and sustained use of medicines.